Evidence of multidimensionality in the ALSFRS-R Scale: A critical appraisal on its measurement properties using Rasch analysis

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 12, 2013, Pages 1340-1345

  Franchignoni, Franco ^a   Mora, Gabriele ^a   Giordano, Andrea ^a   Volanti, Paolo ^a   Chiò, Adriano ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMYOTROPHIC LATERAL SCLEROSIS; AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE REVISED; ARTICLE; CLASSICAL TEST THEORY; DIMENSIONALITY ANALYSIS; EXPLORATORY FACTOR ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; PARALLEL ANALYSIS; PRIORITY JOURNAL; PSYCHOMETRY; RASCH ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL PARAMETERS;

EID: 84888055648     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304701     Document Type: Article

References (29)

1. Orrell RW. Motor neuron disease: systematic reviews of treatment for ALS and SMA. Br Med Bull 2010;93:145-59.
2. Beghi E, Chiò A, Couratier P, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler 2011;12:1-10.
3. Swash M. We have a problem: why have ALS trials been negative? Amyotroph Lateral Scler 2007;8:259.
4. Chiò A, Canosa A, Gallo S, et al. ALS clinical trials: do enrolled patients accurately represent the ALS population? Neurology 2011;77:1432-7.
5. The ALS CNTF treatment study (ACTS) phase I-II Study Group. The amyotrophic lateral sclerosis functional rating scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-7.
6. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
7. Kaufmann P, Ley G, Thompson JLP, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64:38-43.
8. Kollewe K, Mauss U, Krampfl K, et al. ALSFRS-R score and its ratio: a useful predictor for ALS-progression. J Neurol Sci 2008;275:69-73.
9. Gordon PH, Miller RG, Moore DH. ALSFRS-R. Amyotroph Lateral Scler Other Motor Neuron Disord 2004;5(Suppl 1):90-3.
10. Kaufmann P, Levy G, Montes J, et al. Excellent inter-rater, intra-rater, and telephone-administered reliability of the ALSFRS-R in a multicenter clinical trial. Amyotroph Lateral Scler 2007;8:42-6.
11. Hobart JC, Cano SJ, Zajicek JP, et al. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol 2007;6:1094-105.
12. Conrad KJ, Smith EV Jr. International Conference on objective measurement. Applications of Rasch analysis in health care. Med Care 2004;42(Suppl 1):I1-6.
13. Brooks BR, Miller RG, Swash M, et al. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
14. Brooks B. Amyotrophic lateral sclerosis clinimetric scales. In: Herndon RM, ed. Handbook of neurologic rating scales, 2nd edn. New York: Demos Medical Publishing 2006;93-144.
15. Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965;30:179-85.
16. Jöreskog KG, Sörbom D. LISREL 8 user's reference guide, 2nd edn. Lincolnwood: Scientific Software International, 1999.
17. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equat Model 1999;6:1-55.
18. Bond TG, Fox CM. Applying the Rasch model: fundamental measurement in the human sciences, 2nd edn. Mahwah, New Jersey: Lawrence Erlbaum Associates, 2007;219-33.
19. Linacre JM. Optimizing rating scale category effectiveness. J Appl Meas 2002;3:85-106.
20. Linacre JM. A user's guide to WINSTEPS-MINISTEP: Rasch-model computer programs. Program manual 3.68.2. Chicago, Illinois: WINSTEPS.com. 2009.
21. Franchignoni F, Giordano A, Sartorio F, et al. Suggestions for refinement of the Disabilities of the Arm, Shoulder and Hand Outcome Measure (DASH): A factor analysis and Rasch validation study. Arch Phys Med Rehabil 2010;91:1370-7.
22. Hagell P, Nygren C. The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: implications for evidence based medicine. J Neurol Neurosurg Psychiatry. 2007;78:1191-8.
23. Ohashi Y, Tashiro K, Itoyama Y, et al. Study of functional rating scale for amyotrophic lateral sclerosis: revised ALSFRS (ALSFRS-R). No To Shinkei 2001;53:346-55.
24. Campos TS, Rodríguez-Santos F, Esteban J, et al. Spanish adaptation of the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). Amyotroph Lateral Scler 2010;11:475-7.
25. Kasarskis EJ, Dempsey-Hall L, Thompson MM, et al. Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R. Amyotroph Lateral Scler 2005;6:50-4.
26. Grimby G, Tennant A, Tesio L. The use of raw scores from ordinal scales: time to end malpractice? J Rehabil Med 2012;44:97-8.
27. Traynor BJ, Zhang H, Shefner JM, et al. Functional outcome measures as clinical trial endpoints in ALS. Neurology 2004;63:1933-5.
28. Wicks P, Massagli MP, Wolf C, et al. Measuring function in advanced ALS: validation of ALSFRS-EX extension items. Eur J Neurol 2009;16:353-9.
29. Gordon PH, Cheng B, Salachas F, et al. Progression in ALS is not linear but is curvilinear. J Neurol 2010;257:1713-7.